The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex (Q38718857)

5 September 2017

title

The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex (English)

1 reference

protein-protein interaction

5 September 2017

main subject

1 reference

Erratum: The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex

inferred from title

corrigendum / erratum

0 references

author

Evelyne Lima-Fernandes

Evelyne Lima-Fernandes

9

0 references

Gary G. Chiang

Gary G Chiang

36

0 references

Cheryl Arrowsmith

Cheryl H Arrowsmith

35

0 references

Dalia Barsyte-Lovejoy

32

Dalia Barsyte-Lovejoy

1 reference

5 September 2017

Magdalena M. Szewczyk

10

Magdalena M Szewczyk

1 reference

5 September 2017

Yupeng He

1

1 reference

5 September 2017

Sujatha Selvaraju

2

1 reference

5 September 2017

Michael L Curtin

3

1 reference

5 September 2017

Clarissa G Jakob

4

1 reference

5 September 2017

Haizhong Zhu

5

1 reference

5 September 2017

Kenneth M Comess

6

1 reference

5 September 2017

Bailin Shaw

7

1 reference

5 September 2017

Juliana The

8

1 reference

5 September 2017

Dong Cheng

11

1 reference

5 September 2017

Kelly L Klinge

12

1 reference

5 September 2017

Huan-Qiu Li

13

1 reference

5 September 2017

Marina Pliushchev

14

1 reference

5 September 2017

Mikkel A Algire

15

1 reference

5 September 2017

David Maag

16

1 reference

5 September 2017

Jun Guo

17

1 reference

5 September 2017

Justin Dietrich

18

1 reference

5 September 2017

Sanjay C Panchal

19

1 reference

5 September 2017

Andrew M Petros

20

1 reference

5 September 2017

Ramzi F Sweis

21

1 reference

5 September 2017

Maricel Torrent

22

1 reference

5 September 2017

Lance J Bigelow

23

1 reference

5 September 2017

Guillermo Senisterra

24

1 reference

5 September 2017

Fengling Li

25

1 reference

5 September 2017

Steven Kennedy

26

1 reference

5 September 2017

Qin Wu

27

1 reference

5 September 2017

Donald J Osterling

28

1 reference

5 September 2017

David J Lindley

29

1 reference

5 September 2017

Wenqing Gao

30

1 reference

5 September 2017

Scott Galasinski

31

1 reference

5 September 2017

Masoud Vedadi

33

1 reference

5 September 2017

Fritz G Buchanan

34

1 reference

5 September 2017

Chaohong Sun

37

1 reference

5 September 2017

William N Pappano

38

1 reference

5 September 2017

publication date

30 January 2017

1 reference

5 September 2017

published in

Nature Chemical Biology

1 reference

5 September 2017

volume

13

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

389-395

1 reference

A gene complex controlling segmentation in Drosophila

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The Polycomb complex PRC2 and its mark in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Role of histone H2A ubiquitination in Polycomb silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Transcriptional regulation by Polycomb group proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

A model for transmission of the H3K27me3 epigenetic mark

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Role of the polycomb protein EED in the propagation of repressive histone marks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The polycomb-group gene Ezh2 is required for early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The polycomb group protein Suz12 is required for embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

High-density miniaturized thermal shift assays as a general strategy for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Thermal denaturation assays in chemical biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Molecular recognition of histone H3 by the WD40 protein WDR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

A new world of Polycombs: unexpected partnerships and emerging functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Cause and consequences of genetic and epigenetic alterations in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Epigenetic protein families: a new frontier for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Recognition and Specificity Determinants of the Human Cbx Chromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Data processing and analysis with the autoPROC toolbox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Phasercrystallographic software

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Coot: model-building tools for molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Refinement of macromolecular structures by the maximum-likelihood method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

Mechanisms of polycomb gene silencing: knowns and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

7 January 2021

inferred from DOI database lookup

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

7 January 2021

inferred from DOI database lookup

Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.2306

7 January 2021

inferred from DOI database lookup

The eed mutation disrupts anterior mesoderm production in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28135237

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NCHEMBIO.2306

1 reference

5 September 2017

1 reference